Home » SEPRACOR TO DELAY SEC FILING AMID PROBE
SEPRACOR TO DELAY SEC FILING AMID PROBE
Sepracor Inc., a drug maker focused on respiratory and central nervous system disorders, said it will delay filing its latest quarterly report until a review of its stock option practices is completed.
MSN Money
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct